| Source HCPCS Code |
|
Target NDC Code |
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0208-01
BRIXADI WEEKLY 8 MG/0.16ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.16 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0216-01
BRIXADI WEEKLY 16MG/0.32ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.32 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0224-01
BRIXADI WEEKLY 24MG/0.48ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.48 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0228-01
BRIXADI MONTH 128MG/0.36ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.36 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0232-01
BRIXADI WEEKLY 32MG/0.64ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.64 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0264-01
BRIXADI MONTH 64 MG/0.18ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.18 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|
C9154
Injection, buprenorphine extended-release (brixadi), 1 mg
|
⇄
|
58284-0296-01
BRIXADI MONTH 96 MG/0.27ML
|
| Detail Information |
| Relationship Start Date |
10/01/2023 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
0.27 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
|
|
|
|